Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2004-7-16
pubmed:abstractText
BACKGROUND: Visual impairment has a profound impact on society. The majority of visually impaired people live in developing countries, and since most disorders leading to visual impairment are preventable or curable, their control is a priority in these countries. Considering the complicated epidemiology of visual impairment and the wide variety of factors involved, region specific intervention strategies are required for every community. Therefore, providing appropriate data is one of the first steps in these communities, as it is in Iran. The objectives of this study are to describe the prevalence and causes of visual impairment in the population of Tehran city; the prevalence of refractive errors, lens opacity, ocular hypertension, and color blindness in this population, and also the familial aggregation of refractive errors, lens opacity, ocular hypertension, and color blindness within the study sample. METHODS DESIGN: Through a population-based, cross-sectional study, a total of 5300 Tehran citizens will be selected from 160 clusters using a stratified cluster random sampling strategy. The eligible people will be enumerated through a door-to-door household survey in the selected clusters and will be invited. All participants will be transferred to a clinic for measurements of uncorrected, best corrected and presenting visual acuity; manifest, subjective and cycloplegic refraction; color vision test; Goldmann applanation tonometry; examination of the external eye, anterior segment, media, and fundus; and an interview about demographic characteristics and history of eye diseases, eye trauma, diabetes mellitus, high blood pressure, and ophthalmologic cares. The study design and eye examination protocol are described. CONCLUSION: We expect that findings from the TES will show the status of visual problems and their causes in the community. This study can highlight the people who should be targeted by visual impairment prevention programs.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-10442910, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-10655192, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-10676793, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-10691457, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11297483, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11320028, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11423445, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11581045, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11733284, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11815334, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11821977, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11864876, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11914201, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11927431, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11973241, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-11973242, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-12084735, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-12084753, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-12185113, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-12185115, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-12386068, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-12528915, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-1420848, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-1806405, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-1923372, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-7704921, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-8512486, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-8600410, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-8942862, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-9063242, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-9071208, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-9486035, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-9499790, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-9596502, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-9780095, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-9791663, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-9797657, http://linkedlifedata.com/resource/pubmed/commentcorrection/12859794-9797662
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1471-2415
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:12859794-Blindness, pubmed-meshheading:12859794-Cataract, pubmed-meshheading:12859794-Color Perception Tests, pubmed-meshheading:12859794-Color Vision Defects, pubmed-meshheading:12859794-Cross-Sectional Studies, pubmed-meshheading:12859794-Developing Countries, pubmed-meshheading:12859794-Eye Color, pubmed-meshheading:12859794-Humans, pubmed-meshheading:12859794-Intraocular Pressure, pubmed-meshheading:12859794-Iran, pubmed-meshheading:12859794-Ocular Hypertension, pubmed-meshheading:12859794-Ophthalmoscopy, pubmed-meshheading:12859794-Prevalence, pubmed-meshheading:12859794-Refraction, Ocular, pubmed-meshheading:12859794-Refractive Errors, pubmed-meshheading:12859794-Research Design, pubmed-meshheading:12859794-Vision, Low, pubmed-meshheading:12859794-Vision Tests, pubmed-meshheading:12859794-Visual Acuity, pubmed-meshheading:12859794-Visually Impaired Persons
pubmed:year
2003
pubmed:articleTitle
The Tehran Eye Study: research design and eye examination protocol.
pubmed:affiliation
Farabi Eye Hospital, School of Medicine, Tehran University of Medical Sciences, Noor Vision Correction Center, Tehran, Iran. hhashemi@noorvision.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't